Pregled bibliografske jedinice broj: 1206036
Free protein S antigen represents more reliable assay for protein S deficiency testing compared with protein S activity and should be used as the first and main test in the diagnostic protocol
Free protein S antigen represents more reliable assay for protein S deficiency testing compared with protein S activity and should be used as the first and main test in the diagnostic protocol // Research and Practice in Thrombosis and Haemostasis / Cushman, Mary (ur.).
Medford: Willey Online, 2022. PB953, 1 (poster, međunarodna recenzija, sažetak, znanstveni)
CROSBI ID: 1206036 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
Free protein S antigen represents more reliable
assay for protein S deficiency testing compared
with protein S activity and should be used as the
first and main test in the diagnostic protocol
Autori
Margetić, Sandra ; Tomić, Franciska ; Vuga, Ivana
Vrsta, podvrsta i kategorija rada
Sažeci sa skupova, sažetak, znanstveni
Izvornik
Research and Practice in Thrombosis and Haemostasis
/ Cushman, Mary - Medford : Willey Online, 2022
Skup
30th Congress of the International Society on Thrombosis and Haemostasis (ISTH2022)
Mjesto i datum
London, Ujedinjeno Kraljevstvo, 09.07.2022. - 13.07.2022
Vrsta sudjelovanja
Poster
Vrsta recenzije
Međunarodna recenzija
Ključne riječi
protein S ; deficiency ; PS activity ; PS antigen
Sažetak
Background: Heterozygous protein S (PS) deficiency is a well known risk factor for thrombophilia with plasma levels of PS of 35-60%. However, diagnostics of PS deficiency using the most common PS activity (PS:Ac) assays is difficult due to interfering preanalytical and analytical factors leading to false positive results. Aims: To investigate whether free PS antigen (fPS:Ag) assay could be used as an initial assay to determine hereditary PS deficiency in order to improve current diagnostic protocol with PS:Ac as first test Methods: PS:Ac (functional clot-based test) and fPS:Ag (immunological test with monoclonal antibody to unbound PS) were measured with commercial assays (Protein S Ac and Innovance Free PS Ag, Siemens Healthineers, Germany) in 133 consecutive patients referred for testing to our laboratory. Results: Results of protein PS:Ac and fPS:Ag testing are presented in Table 1. In 88 (66.2%) patients, both fPS:Ag and PS:Ac were within reference ranges. In 12 (9%) patients both fPS:Ag and PS:Ac were decreased, among which in 11/133 (8.3%) due to pregnancy or warfarin therapy. PS deficiency was confirmed in 1 (0.8%) patient with decreased both PS:Ac and fPS:Ag at two separate occasions. FPS:Ag assay correctly classified all 133 samples as normal and abnormal. In contrast, in 31/133 (24.1%) samples, PS:Ac levels were slightly decreased and confirmed as false positive in retesting, with fPS:Ag levels within reference range. Conclusion(s): This study confirmed that fPS:Ag should be used as first diagnostic step in hereditary protein S testing due to its much lower falsely decreased values and unclear results and less susceptibility to interferences compared to PS:Ac. In the vast majority of patients, in case of normal fPS:Ag result, no further testing is needed. Based on the results obtained in our laboratory we changed our previous practice with PS:Ac as first diagnostic step and applied fPS:Ag as initial and main diagnostic assay (Figure 1).
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti, Farmacija
POVEZANOST RADA
Ustanove:
KBC "Sestre Milosrdnice",
Hrvatsko katoličko sveučilište, Zagreb
Citiraj ovu publikaciju:
Časopis indeksira:
- Web of Science Core Collection (WoSCC)
- Emerging Sources Citation Index (ESCI)
- Scopus